📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cerebrospinal fluid neurofilament light chain levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment. (2021)

First Author: Iwan K

Attributed to: Gene therapy for CLN5 Batten disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/f1000research.54556.2

PubMed Identifier: 35106137

Publication URI: http://europepmc.org/abstract/MED/35106137

Type: Journal Article/Review

Volume: 10

Parent Publication: F1000Research

ISSN: 2046-1402